CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | SHERWIN STEPHEN A Director | Option exercise 10b5-1 | +15,000 | $53.64 | $805K | 30,860 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Option exercise 10b5-1 | +10,000 | $79.79 | $798K | 40,860 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −7,883 | $163.81 | $1.3M | 32,977 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −2,549 | $164.44 | $419K | 30,428 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −6,896 | $165.79 | $1.1M | 23,532 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −5,829 | $166.56 | $971K | 17,703 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Sale 10b5-1 | −1,843 | $167.31 | $308K | 15,860 |
| 2026-06-05 | SHERWIN STEPHEN A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −15,000 | 0 | ||
| 2026-06-05 | SHERWIN STEPHEN A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −10,000 | 0 | ||
| 2026-06-04 | Norwalk Leslie V Director | Sale 10b5-1 | −1,250 | $168.06 | $210K | 2,838 |
| 2026-06-02 | Keswani Sanjay Chandru Chief Medical Officer | Option exercise | +3,212 | 3,212 | ||
| 2026-06-02 | Keswani Sanjay Chandru Chief Medical Officer | Shares withheld for taxes | −1,733 | $154.84 | $268K | 1,479 |
| 2026-06-02 | Keswani Sanjay Chandru Chief Medical Officer | Option exercise · Restricted Stock Unit | −3,212 | 9,634 | ||
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Option exercise 10b5-1 | +24,965 | $81.49 | $2.0M | 59,311 |
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −14,214 | $154.83 | $2.2M | 45,097 |
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −5,466 | $155.46 | $850K | 39,631 |
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −4,216 | $156.77 | $661K | 35,415 |
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −9,521 | $157.62 | $1.5M | 25,894 |
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −3,520 | $158.59 | $558K | 22,374 |
| 2026-06-02 | Cooke Julie Chief Human Resources Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −24,965 | 0 |
Page 5 of 37 · 740 trades